VAERS received and processed
††† 13,725 adverse event reports for Janssen COVID-19 vaccine recipients; median age was 42 years, and 66% were women (Table 1). Among these VAERS reports, 13,294 (97%) were classified as nonserious, and 343 (3%) were classified as serious, including three reports of non-CVST TTS (no deaths). Two of the TTS cases occurred among women aged 30–39 years and one in a woman aged 50–59 years. Each of these women had evidence of large-vessel thrombosis and thrombocytopenia (Table 2). As of April 25, 14 CVST cases had been confirmed (
8), for a total of 17 TTS cases.
CDC and FDA reviewed 88 reports of death after receipt of Janssen COVID-19 vaccine; death certificates were available for 12 (14%). Among the 88 reported decedents, 44 were female, 38 were male, and the sex of six was not reported (Table 1). The median decedent age was 69 years (range = 21–97 years); median interval from vaccination to death was 2 days (range = 0–23 days). All de
In response to citizen s lawsuit
Headlight staff reports
DEMING – The U.S. Bureau of Land Management has told a federal court in New Mexico that it “intends to withdraw” its decision to allow the development of a dolomite mine on public land in the Florida Mountains south of Deming, New Mexico. A Motion for Stay of All Proceedings in Case Number 2:20-cv-00924, filed January 11, 2021, states that a new decision will be issued at some point in 2021, according to the New Mexico Wilderness Alliance.
American Magnesium has sought approval to mine the dolomite, believing it contains magnesium that could be extracted and sold, since early 2017. It originally proposed to transport the dolomite several miles across the city on a conveyor belt to a production facility proposed for the north side of Deming, but later conceded that the rock would need to be transported on trucks, at an estimated 92 daily trips.